Chemotherapy delivered after viral immunogene therapy augments antitumor efficacy via multiple immune-mediated mechanisms - Wikidata - awgldk - TriplyDB

Chemotherapy delivered after viral immunogene therapy augments antitumor efficacy via multiple immune-mediated mechanisms

Chemotherapy delivered after viral immunogene therapy augments antitumor efficacy via multiple immune-mediated mechanisms

http://www.wikidata.org/entity/Q34343736

about

Biologic therapy and gene therapy in the multimodality treatment of malignant pleural mesothelioma Relevance of tumor-infiltrating lymphocytes in breast cancer Hampering immune suppressors: therapeutic targeting of myeloid-derived suppressor cells in cancer The interplay of immunotherapy and chemotherapy: harnessing potential synergies Mesothelioma response to carbon nanotubes is associated with an early and selective accumulation of immunosuppressive monocytic cells Engineered drug resistant γδ T cells kill glioblastoma cell lines during a chemotherapy challenge: a strategy for combining chemo- and immunotherapy A trial of intrapleural adenoviral-mediated Interferon-α2b gene transfer for malignant pleural mesothelioma.Oncolytic adenoviruses armed with thymidine kinase can be traced by PET imaging and show potent antitumoural effects by ganciclovir dosing.The combination of a low-dose chemotherapeutic agent, 5-fluorouracil, and an adenoviral tumor vaccine has a synergistic benefit on survival in a tumor model system.CpG-mediated modulation of MDSC contributes to the efficacy of Ad5-TRAIL therapy against renal cell carcinoma.Neoadjuvant in situ gene-mediated cytotoxic immunotherapy improves postoperative outcomes in novel syngeneic esophageal carcinoma models.Verapamil results in increased blood levels of oncolytic adenovirus in treatment of patients with advanced cancer Low-dose paclitaxel improves the therapeutic efficacy of recombinant adenovirus encoding CCL21 chemokine against murine cancer.The Role of Regulatory T Cells in Mesothelioma.Treatment of a solid tumor using engineered drug-resistant immunocompetent cells and cytotoxic chemotherapy.Post-chemotherapy T-cell recovery is a marker of improved survival in patients with advanced thoracic malignancies.Addition of an induction regimen of antiangiogenesis and antitumor immunity to standard chemotherapy improves survival in advanced malignancies Adenovirus expressing both thymidine kinase and soluble PD1 enhances antitumor immunity by strengthening CD8 T-cell response.Gemcitabine enhances antitumor efficacy of recombinant lipoimmunogen-based immunotherapy.Intrapleural Adenoviral-mediated Endothelial Cell Protein C Receptor Gene Transfer Suppresses the Progression of Malignant Pleural Mesothelioma in a Mouse Model.The anti-fibrotic effect of GV1001 combined with gemcitabine on treatment of pancreatic ductal adenocarcinoma.CIMAvax-EGF: A New Therapeutic Vaccine for Advanced Non-Small Cell Lung Cancer Patients.Contribution of the immune system to the chemotherapeutic response.Management of malignant pleural effusion by suicide gene therapy in advanced stage lung cancer: a case series and literature review.Inflammatory pathways as promising targets to increase chemotherapy response in bladder cancer.Novel mechanism of synergistic effects of conventional chemotherapy and immune therapy of cancer.Immunotherapy for malignant pleural mesothelioma. Current status and future prospects.Cisplatin-induced antitumor immunomodulation: a review of preclinical and clinical evidence.Pilot and Feasibility Trial Evaluating Immuno-Gene Therapy of Malignant Mesothelioma Using Intrapleural Delivery of Adenovirus-IFNα Combined with Chemotherapy.Enhancing the efficacy of adoptive cellular therapy by targeting tumor-induced immunosuppression.Chronic inflammation in urothelial bladder cancer.Tremelimumab for the treatment of malignant mesothelioma.Immune Therapy.Phase II multicenter study of gene-mediated cytotoxic immunotherapy as adjuvant to surgical resection for newly diagnosed malignant glioma Interferon-β lipofection I. Increased efficacy of chemotherapeutic drugs on human tumor cells derived monolayers and spheroids.Immunotherapy for malignant mesothelioma: Reality check.Natural oncolytic activity of live-attenuated measles virus against human lung and colorectal adenocarcinomas.Gene-mediated cytotoxic immunotherapy as adjuvant to surgery or chemoradiation for pancreatic adenocarcinoma.Enhancing immunotherapy using chemotherapy and radiation to modify the tumor microenvironment.Product review on the Anti-PD-L1 Antibody Atezolizumab.

P2860

Q26775614-BBCFC137-CA8C-4B2B-AB43-0D6A32125762 Q26795598-73609005-A9DF-460E-A455-2E5E5EFD0533 Q26863418-7A5290B4-CECA-4003-A5CC-5F5BEB9EBC86 Q28081893-D08CAA7D-6690-4F49-82F2-8912805CEBBA Q28387268-77C287B0-F385-4EC9-BA85-7A771B1C36E3 Q28485036-B69CC108-BE01-4584-9D27-48837D27E4CA Q33923147-D86FABDF-47ED-43B8-8F6A-6DF2E28F0B7A Q34058399-AFA9F8A1-23F5-4CA2-BE04-3582627727E4 Q34808155-EDBAF4BA-8833-449F-B489-51FFA90E8E99 Q35546240-EC9A52D9-69C8-4FBF-B807-A106D1417A98 Q35549847-6D80703A-4B24-4E82-A822-7A27940B82CD Q35665175-2102C700-8249-493B-A03F-81573765FD5E Q35713347-B2CCE93A-1CD1-40C9-A3FF-2C683F3A4FF8 Q36101238-9656C50B-3B48-4316-8A8F-301C2E98C554 Q36114222-255D7CD4-23BC-4895-9202-D02072E89127 Q36287976-3ACC1510-7B1E-489A-A09E-324D7007F94B Q36420816-352A3B03-5EC3-493F-A19A-56A53F8783FD Q36659314-C1A8B918-077B-4196-8CFA-814065F23EEC Q36821133-D5D960D3-701B-427E-A196-9BBF0045D64D Q37408325-2CF1897A-F6E6-4B98-B340-ED0699E7F8F0 Q37688898-4F5E73C8-E201-4EFA-89A0-D4CA50E13544 Q37695065-5919EAA0-C5C2-47FC-8CD9-ED93B92DB015 Q37832967-56C926DF-E2FE-4F54-8045-5533A6A85D77 Q38022486-17561FC0-A326-4EA0-AF4C-116B660DE463 Q38027501-90405B04-A5A7-40FC-984E-9B113847DB4D Q38083001-8DBCE408-0E9F-4315-BB34-7166936BB78A Q38180749-137FC67D-82F7-4ECF-9549-9AD7626DD0A8 Q38247492-CCBE2E73-8180-4B0B-A6B5-DDBE1305D62C Q38416306-0FB6B29D-16C4-4EB5-B2BA-AE6DDB827D3C Q38525024-A2EF770D-EB79-4FD3-AD96-4D34EC827149 Q38564597-4A4184E2-16A6-4ADF-83CC-31B65EAFB2F5 Q38631254-AAE60792-082B-4519-A939-207086FD446F Q38669273-F7753E59-50B5-4AAC-9D47-190E68C59255 Q38912327-08A7DFBB-13BC-4CA4-9B60-F1CE49A9B102 Q39346521-D01E9011-999E-4284-921B-8678E00CD948 Q39351008-AF1C059E-39E0-4C60-8D8E-8EB97224B751 Q39467892-55C0111D-EAAC-4DF7-89EC-637EEE7807AC Q42153454-DFB0E976-8AF1-4DCF-85E6-BCA4E2679E46 Q42848419-9D9D70E9-524E-477B-BF3A-9E1472E12A63 Q45074483-C4E09909-99E0-4E27-A5DF-6CBFD5931B77

P2860

Chemotherapy delivered after viral immunogene therapy augments antitumor efficacy via multiple immune-mediated mechanisms

http://www.wikidata.org/entity/Q34343736

description

2010 nî lūn-bûn

@nan

2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Chemotherapy delivered after v ...... ple immune-mediated mechanisms

@ast

Chemotherapy delivered after v ...... ple immune-mediated mechanisms

@en

Chemotherapy delivered after v ...... ple immune-mediated mechanisms

@nl

type

label

Chemotherapy delivered after v ...... ple immune-mediated mechanisms

@ast

Chemotherapy delivered after v ...... ple immune-mediated mechanisms

@en

Chemotherapy delivered after v ...... ple immune-mediated mechanisms

@nl

prefLabel

Chemotherapy delivered after v ...... ple immune-mediated mechanisms

@ast

Chemotherapy delivered after v ...... ple immune-mediated mechanisms

@en

Chemotherapy delivered after v ...... ple immune-mediated mechanisms

@nl

P1433

Q34343736-8A1F2669-B849-467F-993D-D75F20533EDB

P1476

Q34343736-E18E6823-25CB-4460-820F-605BBDAE3B07

P2093

Q34343736-4E16D365-09BB-4EA1-9C9D-98B1017A51CF

Q34343736-5C2C8728-5DD5-4067-A3E6-D58475C564EA

Q34343736-82F23DE6-1542-4371-A52D-180312E23DFE

Q34343736-95A36897-34D5-43F4-8F33-13ADDFE20AB4

Q34343736-B380D2CF-7C5D-401B-B5BC-BCA320771959

Q34343736-B73CF47A-160B-41B7-AD19-716987044D47

Q34343736-EBD976C6-6A31-4A75-AFA3-32553BF018D0

P2860

Q34343736-0349DFE3-2AAA-4F70-A5C2-623F215FE8E1

Q34343736-08442292-9E71-4659-AB1D-9F50C20253B7

Q34343736-0C67466B-4EE9-4D9F-954B-5913F4AFB406

Q34343736-0E2E0F0B-892A-4073-A9E0-544AD9764DDA

Q34343736-1BD1262B-3420-47A6-9120-DE1C657E5E1B

Q34343736-20925BDD-4F28-46B0-81C8-2C99F2CA9774

Q34343736-24206797-4ABB-460C-88BF-F6FEAEF6A937

Q34343736-2B6F1E4D-7CA7-449B-84A9-CE54E062711C

Q34343736-2CF664F7-A422-42C5-942F-2BB4E1B4C819

Q34343736-30FA5290-D730-45AB-A651-28C959074690

P304

Q34343736-B97B4812-4BAF-4EEE-BF5B-BD3C8D9E44B5

P31

Q34343736-FF919FAB-7D33-45C9-B135-5E1EF91A394B

P356

Q34343736-9082CD4D-CB58-49CE-AC24-8956E11A550E

P433

Q34343736-25E2EF22-406F-49F9-B74C-0726A4EACBBC

P478

Q34343736-9F4A7118-7256-46CB-86A4-43797B725496

P577

Q34343736-4CFC7BCD-C8A3-4E0D-A5C3-128A107CC3E5

P5875

Q34343736-F1AD3465-B0CB-4D9B-AF62-F0F8EBB3AC72

P698

Q34343736-2602E4F1-F144-4B99-9D24-5452F643C6E3

P921

Q34343736-50F66CCD-B28D-4020-9752-8BB8080A5608

P932

Q34343736-AE505548-7CE4-45B8-88C7-9FD788AB63A1

P356

P1433

Molecular Therapy

P1476

Chemotherapy delivered after v ...... ple immune-mediated mechanisms

@en

P2093

Eiji Suzuki

http://www.w3.org/2001/XMLSchema#string

Guanjun Cheng

http://www.w3.org/2001/XMLSchema#string

Jing Sun

http://www.w3.org/2001/XMLSchema#string

Steven M Albelda

http://www.w3.org/2001/XMLSchema#string

Sunil Singhal

http://www.w3.org/2001/XMLSchema#string

Veena Kapoor

http://www.w3.org/2001/XMLSchema#string

Zvi G Fridlender

http://www.w3.org/2001/XMLSchema#string

P2860

A randomized phase II study of concurrent docetaxel plus vaccine versus vaccine alone in metastatic androgen-independent prostate cancer

Calreticulin exposure dictates the immunogenicity of cancer cell death

Inhibition of NF-kappaB sensitizes non-small cell lung cancer cells to chemotherapy-induced apoptosis.

Chemotherapy enhances tumor cell susceptibility to CTL-mediated killing during cancer immunotherapy in mice.

T-cell adoptive therapy of tumors: mechanisms of improved therapeutic performance.

Towards a better way to die with chemotherapy: role of heat shock protein exposure on dying tumor cells.

NF-kappa B: arresting a major culprit in cancer.

Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells.

Does the immune system see tumors as foreign or self?

Enhancing efficacy of therapeutic vaccinations by combination with other modalities.

P304

1947-1959

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/MT.2010.159

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P577

2010-08-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45494780

http://www.w3.org/2001/XMLSchema#string

P698

20683443

http://www.w3.org/2001/XMLSchema#string

P921

P932

2990510

http://www.w3.org/2001/XMLSchema#string